We are committed to working with key stakeholders, including the US Food and Drug Administration (FDA), to help accelerate the development of life-changing therapies. Below are our priorities to accelerate therapeutic development.
MDA's Accelerating Therapy Development Priorities
Advocate for innovative ways to accelerate therapeutic development and FDA regulatory review so patients can gain access to life-changing treatments sooner.
Ensure the successful implementation of the many FDA and clinical trial reforms MDA advocates helped pass in 2022.
Ensure the continued success of the Orphan Drug Act, which has led to many vital therapies for rare diseases.
Ensure the FDA hears from the neuromuscular community perspective and to gain an appreciation for the factors that are taken into account by patients when a treatment is chosen.
Thanks for trying to take action! There’s no need to act on this campaign because either your elected officials were not included or there’s currently a vacancy in your district.
Thanks for trying to take action! Unfortunately, we could not send your message because:
None of the officials targeted in this campaign accept the type of communication chosen by your organization.
No further action is needed at this time. Thank you again.
Thank you for trying to take action. Unfortunately, none of your officials accept this type of communication.
Please do not close this window. You will need to come back to this window to enter your code.
We just sent an email to ... containing a verification code.
If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
Enter Your Info
Your Information
By providing your mobile number, you agree to receive periodic call to action text messages from Muscular Dystrophy Association. Message and data rates may apply. Reply HELP for help. Reply STOP to unsubscribe. Message frequency varies.
Privacy Policy
Please enter a valid mobile phone number.
You must text "START" to +17736927953 because you previously un-subscribed.
Home Information
Enter Zip for City and State
Business Information
Enter Zip for City and State
Enter Your Info
Additional Information
Your message has not been sent! Your officials require the following additional information to be submitted in order for this message to be delivered to them.
The prefix you selected is not accepted by at least one of your legislators. Please choose one of the following prefixes:
